Dr. Stanger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 King of Prussia Rd
Radnor, PA 19087
Education & Training
Massachusetts General HospitalFellowship, Gastroenterology, 1999 - 2003
Harvard Medical SchoolClass of 1997
Certifications & Licensure
PA State Medical License 2006 - 2024
MA State Medical License 2000 - 2017- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 44 citationsDoublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor CellsDongfeng Qu, Jeremy J. Johnson, Parthasarathy Chandrakesan, Nathaniel Weygant, Randal May
Plos One. 2015-02-27 - 28 citationsOverexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, Parthasarathy Chandrakesan, William L. Berry
Journal of Oncology. 2019-08-05 - 806 citationsRIP : a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell deathBen Z. Stanger, Philip Leder, Tae Ho Lee, Emily Kim, Brian Seed
Cell. 1995-05-19
Press Mentions
Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study ShowsMarch 14th, 2023- Study Suggests New Anti-KRAS Drug as a Strong Candidate for Pancreatic Cancer Clinical TrialsDecember 6th, 2022
- Unprecedented Results Seen in Preclinical Models Indicate Cooperation with the Immune System to Attack Cancer — ScienceDailyDecember 6th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
